Hadi Karami

930 total citations
41 papers, 766 citations indexed

About

Hadi Karami is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Hadi Karami has authored 41 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Cancer Research and 5 papers in Immunology. Recurrent topics in Hadi Karami's work include MicroRNA in disease regulation (11 papers), RNA Interference and Gene Delivery (9 papers) and Circular RNAs in diseases (7 papers). Hadi Karami is often cited by papers focused on MicroRNA in disease regulation (11 papers), RNA Interference and Gene Delivery (9 papers) and Circular RNAs in diseases (7 papers). Hadi Karami collaborates with scholars based in Iran, Malaysia and Denmark. Hadi Karami's co-authors include Fariba Badrzadeh, Samad Mussa Farkhani, Samane Mohammadi, Nasrin Sohrabi, Alireza Valizadeh, Behzad Baradaran, Ebrahim Sakhinia, Maryam Baazm, Ali Esfahani and Mohammad Amini and has published in prestigious journals such as SHILAP Revista de lepidopterología, Free Radical Biology and Medicine and Gene.

In The Last Decade

Hadi Karami

40 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hadi Karami Iran 16 479 185 68 64 63 41 766
Sílvio Roberto Consonni Brazil 16 336 0.7× 130 0.7× 87 1.3× 58 0.9× 46 0.7× 56 806
Dan Zhao China 17 450 0.9× 97 0.5× 52 0.8× 84 1.3× 34 0.5× 58 857
Mingzhu Lei China 18 440 0.9× 217 1.2× 146 2.1× 113 1.8× 82 1.3× 31 957
Dongxu Wang China 14 362 0.8× 146 0.8× 86 1.3× 76 1.2× 49 0.8× 53 593
Yanling Lin China 18 415 0.9× 177 1.0× 110 1.6× 70 1.1× 30 0.5× 61 1.0k
Yajing Liu China 8 442 0.9× 153 0.8× 55 0.8× 56 0.9× 21 0.3× 16 734
Mengjie Wang China 16 468 1.0× 217 1.2× 27 0.4× 98 1.5× 20 0.3× 65 818
Roberta Bernardini Italy 19 370 0.8× 94 0.5× 122 1.8× 163 2.5× 69 1.1× 50 1.0k
Walaa A. El‐Dakroury Egypt 22 470 1.0× 383 2.1× 80 1.2× 32 0.5× 127 2.0× 66 989
Shuang Zhao China 17 512 1.1× 147 0.8× 80 1.2× 70 1.1× 69 1.1× 58 843

Countries citing papers authored by Hadi Karami

Since Specialization
Citations

This map shows the geographic impact of Hadi Karami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hadi Karami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hadi Karami more than expected).

Fields of papers citing papers by Hadi Karami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hadi Karami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hadi Karami. The network helps show where Hadi Karami may publish in the future.

Co-authorship network of co-authors of Hadi Karami

This figure shows the co-authorship network connecting the top 25 collaborators of Hadi Karami. A scholar is included among the top collaborators of Hadi Karami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hadi Karami. Hadi Karami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karami, Hadi, et al.. (2024). The Effects of ABT-199 and Dihydroartemisinin Combination on Cell Growth and Apoptosis in Human U937 and KG-1 Cancer Cells. Asian Pacific Journal of Cancer Prevention. 25(1). 343–350. 2 indexed citations
2.
Karami, Hadi, et al.. (2024). Dihydroartemisinin Enhances the Therapeutic Efficacy of BH3 Mimetic Inhibitor in Acute Lymphoblastic Leukemia Cells via Inhibition of Mcl-1. Asian Pacific Journal of Cancer Prevention. 25(1). 325–332. 2 indexed citations
3.
Nejati, Majid, et al.. (2024). The Combination of 5-FU and Resveratrol Can Suppress the Growth of Glioblastoma Cells Through Downregulation of TRPM2 and β-Catenin. Journal of Molecular Neuroscience. 74(1). 7–7. 4 indexed citations
4.
Karami, Hadi, et al.. (2023). Triggering of Endoplasmic Reticulum Stress by Tannic Acid Inhibits the Proliferation and Migration of Colorectal Cancer Cells. Asian Pacific Journal of Cancer Prevention. 24(8). 2705–2711. 6 indexed citations
5.
Baazm, Maryam, et al.. (2023). Resveratrol ameliorates spermatogenesis by increasing protamine 1, 2 and HSPA2 expression in experimental varicocele rat model. Revista Internacional de Andrología. 21(4). 100370–100370. 3 indexed citations
6.
Karami, Hadi, et al.. (2023). Induction of Unfolded Protein Response by Tannic Acid Triggers Apoptosis in MDA-MB-231 Breast Cancer Cells. Asian Pacific Journal of Cancer Prevention. 24(6). 2029–2035. 4 indexed citations
7.
Baradaran, Behzad, et al.. (2022). Dual Targeting of Anti-Apoptotic Proteins Enhances Chemosensitivity of the Acute Myeloid Leukemia Cells. Asian Pacific Journal of Cancer Prevention. 23(7). 2523–2530. 3 indexed citations
8.
9.
Karami, Hadi, et al.. (2021). MiRNA-Mediated Knock-Down of Bcl-2 and Mcl-1 Increases Fludarabine-Sensitivity in CLL-CII Cells. Asian Pacific Journal of Cancer Prevention. 22(7). 2191–2198. 7 indexed citations
10.
11.
12.
Karami, Hadi, et al.. (2020). A comparative study of the antidiabetic effect of two training protocols in streptozotocin-nicotinamide diabetic rats. Hormone Molecular Biology and Clinical Investigation. 41(2). 3 indexed citations
13.
Esfarjani, Fahimeh, et al.. (2019). Effects of Eight Weeks of Aerobic Training on Expression Levels of the HMGB1-RAGE/TLR4-NF-kB Proinflammatory Pathway in Cardiac Tissue of Male Rats with Hyperglycemia. Majallah-i ghudad-i darūn/rīz va mitābulīsm-i Īrān./Majallah-i ghudad-i darūn/rīz va mitābulīsm-i Īrān.. 20(5). 246–252. 1 indexed citations
14.
Rezaei, Tayebeh, Mohammad Amini, Zahra Sadat Hashemi, et al.. (2019). microRNA-181 serves as a dual-role regulator in the development of human cancers. Free Radical Biology and Medicine. 152. 432–454. 80 indexed citations
15.
Baazm, Maryam, et al.. (2019). Targeting Epidermal Growth Factor Receptor by MiRNA-145 Inhibits Cell Growth and Sensitizes NSCLC Cells to Erlotinib. Asian Pacific Journal of Cancer Prevention. 20(9). 2781–2787. 18 indexed citations
16.
Majidinia, Maryam, Vahid Shafiei‐Irannejad, Rana Jahanban‐Esfahlan, et al.. (2017). Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin. Gene. 642. 249–255. 24 indexed citations
17.
Karami, Hadi, et al.. (2014). Down-Regulation of Mcl-1 by Small Interference RNA Induces Apoptosis and Sensitizes HL-60 Leukemia Cells to Etoposide. Asian Pacific Journal of Cancer Prevention. 15(2). 629–635. 24 indexed citations
18.
Yousefi, Bahman, Zeinab Faghfoori, Nasser Samadi, et al.. (2014). The effects of Ramadan fasting on endothelial function in patients with cardiovascular diseases. European Journal of Clinical Nutrition. 68(7). 835–839. 33 indexed citations
19.
Farkhani, Samad Mussa, Alireza Valizadeh, Hadi Karami, et al.. (2014). Cell penetrating peptides: Efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules. Peptides. 57. 78–94. 221 indexed citations
20.
Karami, Hadi, Behzad Baradaran, Ali Esfahani, et al.. (2013). siRNA-mediated Silencing of Survivin Inhibits Proliferation and Enhances Etoposide Chemosensitivity in Acute Myeloid Leukemia Cells. Asian Pacific Journal of Cancer Prevention. 14(12). 7719–7724. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sílvio Roberto Consonni Breakdown of academic impact, for papers by Dan Zhao Breakdown of academic impact, for papers by Mingzhu Lei Breakdown of academic impact, for papers by Dongxu Wang Breakdown of academic impact, for papers by Yanling Lin Breakdown of academic impact, for papers by Yajing Liu Breakdown of academic impact, for papers by Mengjie Wang Breakdown of academic impact, for papers by Roberta Bernardini Breakdown of academic impact, for papers by Walaa A. El‐Dakroury Breakdown of academic impact, for papers by Shuang Zhao
Rankless by CCL
2026